Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis: a commentary on the proposed EU pharma regulation.
Astrid Berner-RodoredaFrank CobelensAnne-Mieke VandammeGünter FroeschlJolene SkordisElil RenganathanEllen t'HoenMario RaviglioneAlbrecht JahnTill BärnighausenPublished in: BMJ global health (2024)